Demographic and Clinical Features of 1,641 Patients with Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Single-Center Retrospective Study

被引:16
|
作者
Uzuncakmak, Tugba Kevser [1 ]
Engin, Burhan [1 ]
Serdaroglu, Server [1 ]
Tuzun, Yalcin [1 ]
机构
[1] Istanbul Univ Cerrahpasa, Med Fac, Dept Dermatol, Dr Erkin St, TR-34722 Istanbul, Turkey
来源
SKIN APPENDAGE DISORDERS | 2021年 / 7卷 / 01期
关键词
Alopecia areata; Alopecia totalis; Alopecia universalis; Epidemiology; AUTOIMMUNE-DISEASE; PROFILE; EPIDEMIOLOGY; PREVALENCE;
D O I
10.1159/000510880
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background/Aim: Alopecia areata (AA) is a common autoimmune hair disorder which is characterized by noncicatricial hair loss. AA commonly presents with localized patches on the scalp and face but may affect any hair-bearing region of the body leading to even more generalized involvement. AA may affect any age group, gender, and race. The current study investigates the demographic characteristics of the patients with AA and subgroups of AA including alopecia totalis (AT) and alopecia universalis (AU) and the prevalence of disease, sex, and age distribution and seasonal variation retrospectively in a tertiary dermatology clinic in Turkey. Materials and Methods: In this retrospective, cross-sectional study, 1,641 patients diagnosed with AA, AT, and AU in the dermatology clinic of a public university hospital were included. The dermatology outpatient database was reviewed retrospectively. The diagnosis of AA was based on patient history, clinical examinations, and histopathologic findings. Results: Fifty-four thousand one hundred sixty-eight patients were admitted to our outpatient clinic in 4 years time, and 1,641 were diagnosed as having AA, AT, and AU. One thousand three hundred ninety-two patients (84.8%) had AA, 81 (4.9%) had AT, and 168 (10.2%) had AU. Among the 1,641 patients included in the study, 877 were females (53.4%) and 764 were males (46.6%). The mean age was 29.86 +/- 14.48 years in AA, 29.50 +/- 16.18 in AT, and 32.81 +/- 14.48 in AU; 77.4, 72.8, and 68.5% of patients were aged under 40 years in AA, AT, and AU. There was no statistically significant difference in seasonal presentation times. Conclusion: AA is affecting approximately 2% of the general population without any sex, race, or age group predilection. In this study, we found a lower prevalence of AA in the pediatric age group in comparison with adults. This finding may support the hypothesis of the increasing prevalence of AA over time. The higher ratio of AA regarding this study may support that the frequency of AA and subtypes varies between regions.
引用
收藏
页码:8 / 12
页数:5
相关论文
共 50 条
  • [41] A novel predictive model for the recurrence of pediatric alopecia areata by bioinformatics analysis and a single-center prospective study
    Zheng, Yuanquan
    Nie, Yingli
    Lu, Jingjing
    Yi, Hong
    Fu, Guili
    FRONTIERS IN MEDICINE, 2023, 10
  • [42] Retrospective study correlating the clinical outcome of alopecia areata with specific prognostic factors
    Starace, Michela
    Alessandrini, Aurora Maria
    Cua, Val Constantine S.
    Cucinotta, Federico Francesco
    Bruni, Francesca
    Iorizzo, Matilde
    Piraccini, Bianca Maria
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (04) : E499 - E500
  • [43] Epidemiological, Clinical, Trichoscopic, and Histopathological Features of Lupus Erythematous Mimicking Alopecia Areata: A Multicenter Retrospective Study
    Melo, Daniel Fernandes
    Ramos, Paulo Mueller
    Iorizzo, Matilde
    Lima, Caren dos Santos
    Pinto, Erica Baptista
    de Almeida, Rita Fernanda Cortez
    Machado, Carla Jorge
    Starace, Michela
    SKIN APPENDAGE DISORDERS, 2022, 8 (03) : 236 - 240
  • [44] Safety and efficacy results of a clinical study of efalizumab in patients with alopecia areata
    Price, V.
    Hordinsky, M.
    Leonardi, C.
    Roberts, J.
    Olsen, E.
    Rafal, E.
    Korman, N.
    Leung, H.
    Garovoy, M.
    Caro, I.
    Whiting, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 105 - 105
  • [45] Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
    Serdaroglu, Server
    Engin, Burhan
    Celik, Ugur
    Erkan, Emine
    Askin, Ozge
    Oba, Cigdem
    Kutlubay, Zekayi
    DERMATOLOGIC THERAPY, 2019, 32 (03)
  • [46] Photographic assessment improves adherence to recommended follow-up in patients with androgenetic alopecia and alopecia areata: A retrospective cohort study
    Lee, Solam
    Lee, Hanil
    Lee, Chung Hyeok
    Lee, Won-Soo
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2019, 85 (04): : 431 - 433
  • [47] Reduced incidence of skin cancer in patients with alopecia areata: A retrospective cohort study
    Mostaghimi, Arash
    Qureshi, Sarah
    Joyce, Cara
    Guo, Ye
    Huang, Kathie P.
    CANCER EPIDEMIOLOGY, 2016, 41 : 129 - 131
  • [48] Prognosis in patients with alopecia areata with poliosis: A retrospective cohort study of 479 cases
    Lim, Sung Ha
    Kang, Hyun
    Jung, Seung-Won
    Lee, Won-Soo
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2023, 89 (04): : 595 - 597
  • [49] Low-dose oral minoxidil for alopecia: a single-center retrospective review
    Zhu, Yinhua
    Li, Edward
    Quan, Victor
    Colavincenzo, Maria
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB62 - AB62
  • [50] Diffuse pattern of alopecia areata in children: A multicentre retrospective study with 67 patients
    Buzatto, Brenda Costa
    Lemes, Luciana Rodino
    de Almeida, Rita Fernanda Cortez
    Machado, Carla Jorge
    Starace, Michela
    Piraccini, Bianca Maria
    Alessandrini, Aurora
    Quadrelli, Federico
    Marti, Miguel
    Rudnicka, Lidia
    Burnat, Anna Waskiel
    Doroshkevich, Andrei
    Silyuk, Tatiana
    Iorizzo, Matilde
    Rigatti, Marcelo
    Tosti, Antonella
    Vincenzi, Colombina
    Mercau, Sebastian
    Sanchez-Duenas, Luis Enrique
    Sigall, Daniel Asz
    Lima, Caren dos Santos
    Baptista, Erica
    de Carvalho, Raquel
    Faro, Gustavo Baptista de Almeida
    Doche, Isabella
    Melo, Daniel Fernandes
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (09) : e802 - e806